Surveying the adaptive landscapes of 10,000 antibodies

Abstract

Affinity maturation is the Darwinian process by which antibodies improve antigen binding through somatic hypermutation and selection. The adaptive landscape, which defines the set of antibody-specific mutations that improve functional characteristics like antigen binding, has been explored in only a handful of antibodies. Identifying the sites of adaptive mutations in a given antibody sequence, and how these sites vary across the antibody repertoire, can inform the design of therapeutic antibodies. We develop a parameter-free population genetic framework that leverages the statistics of convergent affinity maturation in B cell lineages sharing similar naive sequences, called public clonotypes, to identify beneficial mutations. Applying this framework to more than 10,000 public clonotypes represented by multiple lineages across 20 healthy individuals, we identify widespread signatures of clonotype-dependent selection of individual mutations. We estimate the prevalence and typical fitness effects of mutations across the V gene at the single-site level, uncovering a general tradeoff between prevalence and fitness effect. These inferred landscapes broadly reproduce the statistics of convergent mutation in antibodies specific to SARS-CoV-2 and influenza. Finally, we use our framework to benchmark predictions from existing antibody language models, and show that while these models are dominated by non-selective signatures, a simple renormalization procedure can expose signatures of clonotype-dependent positive selection consistent with our predictions.